efonidipine has been researched along with dehydroepiandrosterone sulfate in 1 studies
| Studies (efonidipine) | Trials (efonidipine) | Recent Studies (post-2010) (efonidipine) | Studies (dehydroepiandrosterone sulfate) | Trials (dehydroepiandrosterone sulfate) | Recent Studies (post-2010) (dehydroepiandrosterone sulfate) |
|---|---|---|---|---|---|
| 129 | 18 | 30 | 4,127 | 412 | 946 |
| Protein | Taxonomy | efonidipine (IC50) | dehydroepiandrosterone sulfate (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Saito, T; Tojo, K | 1 |
1 other study(ies) available for efonidipine and dehydroepiandrosterone sulfate
| Article | Year |
|---|---|
Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
Topics: Adrenocortical Carcinoma; Angiotensin II; Bucladesine; Calcium Channel Blockers; Cell Line, Tumor; Dehydroepiandrosterone Sulfate; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Nitrophenols; Organophosphorus Compounds; Phosphoproteins; RNA, Messenger; Verapamil | 2011 |